Effect of Smartphone App Postoperative Home Monitoring After Oncologic Surgery on Quality of Recovery
Authors: Temple-Oberle Claire , Yakaback Spencer , Webb Carmen , Assadzadeh Golpira Elmi , Nelson Gregg 
Published: April 2023

Importance

There has been an increase in health care–focused smartphone apps, including those for encouraging healthy behaviors and managing chronic conditions, but app-assisted postsurgical care has yet to be fully explored.

Objective

To compare quality of recovery and patient satisfaction between conventional in-person follow-up and smartphone app–assisted follow-up for patients following Enhanced Recovery After Surgery Society (ERAS) protocols.

Design, Setting, and Participants

This randomized clinical trial, conducted from June 2019 to April 2021, included women older than 18 years undergoing oncologic breast reconstruction or major gynecologic oncology surgery following ERAS protocols with the care of 2 surgeons at an academic tertiary care center.

Interventions

Patients were randomized 1:1 to receive smartphone app–assisted follow-up or conventional in-person follow-up. The smartphone group used a surgeon-monitored app to record Quality of Recovery 15 (QoR15) scores, European Organisation for Research and Treatment of Cancer–selected adverse events, drain outputs, and surgical site photographs over 6 weeks. Patient satisfaction scores were assessed using validated Patient Satisfaction Questionnaire III (PSQ-III) subscales at 2 and 6 weeks postoperatively. The conventional follow-up group also completed the QoR15 and PSQ-III questionnaires at these intervals.

Main Outcomes and Measures

The primary outcomes were quality of recovery and patient satisfaction, as measured by the QoR15 and PSQ-III, respectively. Secondary outcomes were costs of follow-up; the number of contacts with the medical system, complications, and surgeons’ contacts with patients; and surgeons’ perceptions of app-assisted care.

Results

Of 72 patients included in the trial, 36 underwent breast reconstruction (mean [SD] age, 45.30 [9.13] years) and 36 underwent gynecologic oncology surgery (mean [SD] age, 54.90 [11.18] years). Three patients dropped out (2 who underwent breast reconstruction [1 in the app group, 1 in the control group], 1 who underwent gynecologic oncology surgery [control group]). The app group had significantly higher mean (SD) QoR15 scores than the control group (2 weeks: 127.58 [22.03] vs 117.68 [17.52], P = .02; 6 weeks: 136.64 [17.53] vs 129.76 [16.42], P = .03). Patients were equally satisfied between groups in all subsets of the PSQ-III at these intervals. The mean (SD) number of complications was similar in both groups, and a similar number of surgeon contacts per patient occurred (1.6 [1.2] vs 2.1 [2.0], P = .16). Surgeons appreciated early identification of complications with the app.

Conclusions and Relevance

In this randomized clinical trial, postoperative follow-up for patients undergoing breast reconstruction and gynecologic oncology surgery using smartphone app–assisted monitoring led to improved quality of recovery and equal satisfaction with care compared with conventional in-person follow-up.

Trial Registration

ClinicalTrials.gov Identifier: NCT03456167